Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 3 | X027902 | — |
No additional AE reported; Nurse reported patient was mistakenly administered a third dose of MMR II on Mar 10, 2025. Patient received first dose of MMR II on Sep 24, 2024 and second dose of MMR II on Jan 20, 2025. No further information provided by nurse. No additional AE rep; This spontaneous report was received from a nurse and refers to a 64-year-old male patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 24-Sep-2024, the patient received the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Solution for injection (lot # and expiration date were not reported) and on 20-Jan-2025, the patient received the second dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Solution for injection (lot # and expiration date were not reported), both diluted with sterile diluent (MERCK STERILE DILUENT), Solution for injection (indication, expiration date, and lot # were not reported). On 10-Mar-2025, the patient was mistakenly vaccinated with the third dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Solution for injection (lot #X027902, expiration date: 04-Dec-2025) diluted with sterile diluent (MERCK STERILE DILUENT), Solution for injection (indication, expiration date, and lot # were not reported). No additional adverse event was reported. Lot # is being requested and will be submitted if received.
sterile diluent